Skip to main content

LCD L33944: Blepharoplasty

LCD L33944, Blepharoplasty, is the Local Coverage Determination that CGS Administrators, LLC applies to claims from 2 states (KY, OH), effective 2026-11-05 and first in force 2015-10-01. The policy text runs 1,475 words, and its billing and coding article A56439 lists 223 ICD-10-CM codes that support medical necessity for 21 procedure codes. No other contractor publishes a policy with this title.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
CGS Administrators, LLC
States and territories
2
KY OH
Revision effective
2026-11-05
Original effective
2015-10-01
Policy text
1,475 words
Covered ICD-10 codes (articles)
223

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L33944
ContractContractorTypeStates
15102CGS Administrators, LLCMAC - Part BKY
15202CGS Administrators, LLCMAC - Part BOH
15101CGS Administrators, LLCMAC - Part AKY
15201CGS Administrators, LLCMAC - Part AOH

Billing and coding article A56439: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A56439 (Billing and Coding: Blepharoplasty) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A56439: Billing and Coding: Blepharoplasty (Billing and Coding, effective 2025-11-06)

Covered ICD-10-CM codes
223
2 groups
Non-covered ICD-10-CM codes
1
Procedure codes listed
21
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A56439
ICD-10-CMDescription (FY2027)
C44.1021Unspecified malignant neoplasm of skin of right upper eyelid, including canthus
C44.1022Unspecified malignant neoplasm of skin of right lower eyelid, including canthus
C44.1091Unspecified malignant neoplasm of skin of left upper eyelid, including canthus
C44.1092Unspecified malignant neoplasm of skin of left lower eyelid, including canthus
C44.1121Basal cell carcinoma of skin of right upper eyelid, including canthus
C44.1122Basal cell carcinoma of skin of right lower eyelid, including canthus
C44.1191Basal cell carcinoma of skin of left upper eyelid, including canthus
C44.1192Basal cell carcinoma of skin of left lower eyelid, including canthus
C44.1221Squamous cell carcinoma of skin of right upper eyelid, including canthus
C44.1222Squamous cell carcinoma of skin of right lower eyelid, including canthus
C44.1291Squamous cell carcinoma of skin of left upper eyelid, including canthus
C44.1292Squamous cell carcinoma of skin of left lower eyelid, including canthus
C44.131Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus
C44.1321Sebaceous cell carcinoma of skin of right upper eyelid, including canthus
C44.1322Sebaceous cell carcinoma of skin of right lower eyelid, including canthus
C44.1391Sebaceous cell carcinoma of skin of left upper eyelid, including canthus
C44.1392Sebaceous cell carcinoma of skin of left lower eyelid, including canthus
C44.1921Other specified malignant neoplasm of skin of right upper eyelid, including canthus
C44.1922Other specified malignant neoplasm of skin of right lower eyelid, including canthus
C44.1991Other specified malignant neoplasm of skin of left upper eyelid, including canthus
C44.1992Other specified malignant neoplasm of skin of left lower eyelid, including canthus
C44.301Unspecified malignant neoplasm of skin of nose
C44.309Unspecified malignant neoplasm of skin of other parts of face
C44.311Basal cell carcinoma of skin of nose

Procedure codes: 15820, 15821, 15822, 15823, 67900, 67901, 67902, 67903, 67904, 67906, 67908, 67909, 67911, 67914, 67915, 67916, 67917, 67921, 67922, 67923, 67924.

Coverage indications, limitations and medical necessity

Abstract:

Medicare does not cover cosmetic surgery or expenses incurred in connection with such surgery. Cosmetic surgery is defined by Medicare as: “any surgical procedure directed at improving appearance, except when required for the prompt [i.e., as soon as medically feasible] repair of accidental injury or for the improvement of the functioning of a malformed body member. For example, this exclusion does not apply to surgery in connection with treatment of severe burns or repair of the face following a serious automobile accident, or to surgery for therapeutic purposes which coincidentally also serves some cosmetic purpose” (CMS Publication 100-2; Medicare Benefit Policy Manual , Chapter 16, Section 120). This local coverage determination provides additional guidance on CGS covered indications and limitations of coverage for blepharoplasty surgery

The American Society of Plastic and Reconstructive Surgeons has published the following definitions:

• Blepharoplasty may be defined as any eyelid surgery that improves abnormal function, reconstructs deformities, or enhances appearance. It may be either reconstructive or cosmetic (aesthetic).

• Cosmetic Blepharoplasty: When blepharoplasty is performed to improve a patient’s appearance in the absence of any signs or symptoms of functional abnormalities, the procedure is considered cosmetic.

• Reconstructive Blepharoplasty: When blepharoplasty is performed to correct visual impairment caused by drooping of the eyelids (ptosis); repair defects caused by trauma or tumor-ablative surgery (ectropion/entropion corneal exposure); treat periorbital sequelae of thyroid disease and nerve palsy; or relieve the painful symptoms of blepharospasm, the procedure should be considered reconstructive. This may involve rearrangement or excision of the structures with the eyelids and/or tissues of the cheek, forehead and nasal areas. Occasionally a graft of skin or other distant tissues is transplanted to replace deficient eyelid components.

Based upon the above definitions, surgery of the upper eyelids is reconstructive when it provides functional vision and/or visual field benefits or improves the functioning of a malformed or degenerated body member, but cosmetic when done to enhance aesthetic appearance. The goal of functional restorative surgery is to restore significant function to a structure that has been altered by trauma, infection, inflammation, degeneration (e.g., from aging), neoplasia, or developmental errors.

Upper blepharoplasty and/or repair of blepharoptosis may be considered functional in nature when excess upper eyelid tissue or the upper lid position produces functional complaints. Those functional complaints are usually related to visual field impairment in primary gaze and/or down gaze (e.g., reading position). The visual impairment is commonly related to a lower than normal position of the eyelid relative to the pupil and/or to excess skin that hangs over the edge of the eyelid. Upper blepharoplasty may also be indicated for chronic dermatitis due to redundant skin and for patients with an anophthalmic socket who are experiencing prosthesis difficulties. Brow ptosis may also produce or contribute to functional visual field impairment. Either or both of these procedures may be required in some situations when a blepharoplasty would not result in a satisfactory functional repair. Similarly, surgery of the lower eyelids is reconstructive when poor eyelid tone (with or without entropion or ectropion) causes dysfunction of the “lacrimal pump,” lid retraction, and/or exposure keratoconjunctivitis that often results in epiphora (tearing).

The following are terms used to describe conditions which may require repair of the eyelids(s):

• Dermatochalasis: excess skin with loss of elasticity that is usually the result of the aging process.

• Blepharochalasis: excess skin associated with chronic recurrent eyelid edema that physically stretches the skin.

• Blepharoptosis: drooping of the upper eyelid which relates to the position of the eyelid margin with respect to the eyeball and visual axis.

• Pseudoptosis: “false ptosis,” for the purposes of this policy, describes the specific circumstance when the eyelid margin is usually in an appropriate anatomic position with respect to the eyeball and visual axis but the amount of excessive skin from dermatochalasis or blepharochalasis is so great as to overhang the eyelid margin and create its own ptosis. Other causes of pseudoptosis, such as hypotropia and globe malposition, are managed differently and do not apply to this policy. Pseudoptosis resulting from insufficient posterior support of the eyelid, as in phthisis bulbi, microphthalmos, congenital or acquired anophthalmos, or enophthalmos is often correctable by prosthesis modification when a prosthesis is present, although persistent ptosis may be corrected by surgical ptosis repair.

• Brow Ptosis: drooping of the eyebrows to such an extent that excess tissue is pushed into the upper eyelid. It is recognized that in some instances the brow ptosis may contribute to significant superior visual field loss. It may coexist with clinically significant dermatochalasis and/or lid ptosis.

• Horizontal Eyelid Laxity: poor eyelid tone, usually a result of the aging process, that causes (1) lid retraction without frank ectropion formation but with corneal exposure and irritation (foreign body sensation) and (2) dysfunction of the eyelid “lacrimal pump,” both of which result in symptomatic tearing (epiphora).

Indications and Limitations:

The conditions listed under “2” and “3” below are generally considered reconstructive and not subject to the medical review of conditions listed under “1” which have the potential of being considered cosmetic

Blepharoplasty may be considered reconstructive when performed for one of the following conditions that may affect both upper and lower eyelids.

• To correct visual impairment caused by:

• Dermatochalasis, including symptomatic redundant skin weighing down on the upper eyelashes (i.e., pseudoptosis) and surgically induced dermatochalasis after ptosis repair.

• Blepharochalasis.

• Blepharoptosis, including dehiscence of the aponeurosis of the levator palpebrae superioris muscle after trauma or cataract extraction, causing ptosis that may obstruct the superior visual field as well as the visual axis in downgaze (reading position).

• Brow ptosis.

It is recognized that brow ptosis repair, in addition to blepharoplasty and/or blepharoptosis repair, may be necessary in some cases to provide an adequate functional result.

Any procedure(s) involving blepharoplasty and billed to this contractor must be supported by documented patient complaints which justify functional surgery. This documentation must address the signs and symptoms commonly found in association with ptosis, pseudoptosis, blepharochalasis and/or dermatochalasis. These include (but are not limited to):

• Significant interference with vision or superior or lateral visual field, (e.g., difficulty seeing objects approaching from the periphery);

• Difficulty reading due to superior visual field loss; or,

• Looking through the eyelashes or seeing the upper eyelid skin.

The visual fields should demonstrate a significant loss of superior visual field and potential correction of the visual field by the proposed procedures(s). A minimum 12 degree or 30 percent loss of upper field of vision with upper lid skin and/or upper lid margin in repose and elevated (by taping of the lid) to demonstrate potential correction by the proposed procedure or procedures is required. Photographs may be used to demonstrate the eyelid abnormality(ies) necessitating the procedures(s), but are not required. (Photography for purposes of documentation is not seperately reportable or reimbursed.) (Please see “Documentation Requirements.”)

Please note that in the case of prosthetic difficulties associated with an anophthalmic, microphthalmic, or enophthalmic socket, subjective complaints, examination findings (signs), and failure of prosthesis modification (when indicated) must be documented, along with photographic documentation demonstrating the contribution of one of the above mentioned orbital and/or globe abnormalities as they relate to the abnormal upper and/or lower eyelid position and intolerance of prosthesis wear. (Please see “Documentation Requirements.”)

• Repair of anatomical or pathological defects, including those caused by disease (including thyroid dysfunction and cranial nerve palsies), trauma, or tumor-ablative surgery. Surgery is performed to reconstruct the normal structure of the eyelid, using local or distant tissue. Reconstruction may be necessary to protect the eye and/or improve visual function. Conditions that may require blepharoplasty, ptosis repair, ectropion repair, or entropion repair are:

• Ectropion and entropion

• Epiblepharon

• Post-traumatic defects of the eyelid

• Post-surgical defects after excision of neoplasm(s)

• Lagophthalmos

• Congenital lagophthalmos

• Congenital ectropion, entropion

• Congenital ptosis

• Lid retraction or lag (due to horizontal lower eyelid laxity without ectropion or entropion, causing exposure keratopathy and/or epiphora; due to horizontal upper eyelid laxity, causing floppy eyelid syndrome; or due to orbital thyroid disease).

• Chronic symptomatic dermatitis of pretarsal skin caused by redundant upper eyelid skin.

The medical record must contain documented patient complaints and pertinent examination findings to justify the medical necessity for functional, restorative procedures(s) for the treatment of any of the above conditions. (Please see “Documentation Requirements.”) (Photography for purposes of documentation is not separately reportable or reimbursed.)

• Relief of eye symptoms associated with blepharospasm. Primary essential (idiopathic) blepharospasm is characterized by severe squinting, secondary to uncontrollable spasms the peri-ocular facial muscles. Occasionally, it can be debilitating. If other treatments have failed or are contraindicated, a blepharoplasty combined with limited myectomy may be necessary.

Patient complaints and relevant medical history (e.g., failure to respond to botulinum toxin therapy, botulinum toxin therapy is contraindicated, etc.) must be documented and available upon request. Please see “Documentation Requirements.”

Summary of evidence (opening)

N/A

the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2026-11-05
Last reviewed by the contractor
2026-10-20
MCD version
28
Derived from
L31828

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the CGS Administrators, LLC hub lists every other active policy from the same contractor.

Prior authorization in Original Medicare

  • Hospital outpatient departments need prior authorization nationwide for dates of service on or after July 1, 2020; it is a condition of payment for the hospital claim and related claims. CMS service group: Blepharoplasty, blepharoptosis repair and brow ptosis repair. Codes on the CMS list: 15820, 15821, 15822, 15823, 67900, 67901, 67902, 67903, 67904, 67906 and 67908; 67911 was removed on January 7, 2022.
  • Ambulatory surgical centers in the CMS prior authorization demonstration: January 19, 2026 in California, Florida, Georgia, Maryland, New York, Pennsylvania and Tennessee; February 16, 2026 in Arizona, Ohio and Texas; requests are voluntary, and claims without one go to pre-payment review. CMS service group: Blepharoplasty, blepharoptosis repair and brow ptosis repair. Codes on the CMS list: 15820, 15821, 15822, 15823, 67900, 67901, 67902, 67903, 67904, 67906 and 67908.

Medicare Advantage plans run their own prior authorization lists. See the services and codes on the Medicare prior authorization list.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L33944 cover?

Medicare does not cover cosmetic surgery or expenses incurred in connection with such surgery. Cosmetic surgery is defined by Medicare as: “any surgical procedure directed at improving appearance, except when required for the prompt [i.e., as soon as medically feasible] repair of accidental injury or for the improvement of the functioning of a malformed body member. For example, this exclusion does not apply… The full 1,475-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L33944 apply to?

CGS Administrators, LLC applies it to Medicare claims in 2 states: KY, OH. It binds only that contractor; outside these jurisdictions the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L33944?

The companion billing and coding article A56439 lists 223 ICD-10-CM codes in 2 groups that support medical necessity and 1 that do not; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L33944?

A denial under LCD L33944 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A56439's 223 covered diagnosis codes, then file a redetermination with CGS Administrators, LLC within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.